Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)

J. Randolph Hecht, Kyriakos P. Papadopoulos, Gerald S. Falchook, Manish R. Patel, Jeffrey R. Infante, Raid Aljumaily, Deborah J. Wong, Karen A. Autio, Zev A. Wainberg, Todd M. Bauer, Milind Javle, Shubham Pant, Johanna Bendell, Annie Hung, Navneet Ratti, Peter VanVlasselaer, Rakesh Verma, Joseph Leveque, Sujata Rao, Martin OftAung Naing

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)'. Together they form a unique fingerprint.

Medicine & Life Sciences